Deregulation of MiRNA in -Induced Gastric MALT Lymphoma: From Mice to Human

Overview

Journal J Clin Med

Specialty General Medicine

Date 2019 Jun 16

PMID 31200531

Citations 15

Authors

Alice Blosse

Michael Levy

Cyrielle Robe

Cathy Staedel

Christiane Copie-Bergman

Philippe Lehours

Affiliations

Soon will be listed here.

Abstract

Gastric MALT lymphoma (GML) is directly caused by infection but occurs only in a small number of infected subjects. Mechanisms underlying the initiation and progression of GML remain unclear. MicroRNAs (miRNAs) are small non-coding RNAs that are now considered as major players in inflammation and carcinogenesis, acting as oncogenes or tumor suppressors. Previous laboratory studies have shown in a GML mouse model that overexpression of a distinct set of five miRNAs (miR-21a, miR-135b, miR-142a, miR-150, miR-155) could play a critical role in the pathogenesis of GML. Our goal was to compare the miRNA expression profile obtained in the GML mouse model to that in human GML (11 cases of GML compared to 17 cases of gastritis control population). RTqPCR on the five dysregulated miRNAs in the GML mouse model and PCR array followed by RTqPCR confirmation showed that four miRNAs were up-regulated (miR-150, miR-155, miR-196a, miR-138) and two miRNAs down-regulated (miR-153, miR-7) in the stomachs of GML patients vs. gastritis control population. The analysis of their validated targets allowed us to postulate that these miRNAs (except miR-138) could act synergistically in a common signaling cascade promoting lymphomagenesis and could be involved in the pathogenesis of GML.

Citing Articles

Downregulation of miR‑7 and miR‑153 is involved in CagA induced gastric carcinogenesis and progression.

Song Y, Guo D, Liu J, Ge L, Liu P, Qu Y Int J Oncol. 2023; 63(1).

PMID: 37232358 PMC: 10237257. DOI: 10.3892/ijo.2023.5527.

Multiple functions and regulatory network of miR-150 in B lymphocyte-related diseases.

Hu Y, Li Q, Wang P, Li X, Hu Z Front Oncol. 2023; 13:1140813.

PMID: 37182123 PMC: 10172652. DOI: 10.3389/fonc.2023.1140813.

Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications.

Zhao L, Mei J, Yu G, Lei L, Zhang W, Liu K Signal Transduct Target Ther. 2023; 8(1):201.

PMID: 37179402 PMC: 10183032. DOI: 10.1038/s41392-023-01406-7.

A noval prognostic signature of the N7-methylguanosine (m7G)-related miRNA in lung adenocarcinoma.

Duan H, Yan J, Nie L, Wang Y, Xie H BMC Pulm Med. 2023; 23(1):14.

PMID: 36635678 PMC: 9838007. DOI: 10.1186/s12890-022-02290-7.

The role of non-coding RNA in the diagnosis and treatment of -related gastric cancer, with a focus on inflammation and immune response.

Liu A, Yan Z, Jiang L, Lv Z, Li Y, Wang B Front Med (Lausanne). 2022; 9:1009021.

PMID: 36314013 PMC: 9606473. DOI: 10.3389/fmed.2022.1009021.

References

Tankovic J, Lamarque D, Lascols C, Soussy C, Delchier J . Clarithromycin resistance of Helicobacter pylori has a major impact on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy. Pathol Biol (Paris). 2001; 49(7):528-33. DOI: 10.1016/s0369-8114(01)00209-7. View

Ullrich A, Fischbach W, Blettner M . Incidence of gastric B-cell lymphomas: a population-based study in Germany. Ann Oncol. 2002; 13(7):1120-7. DOI: 10.1093/annonc/mdf177. View

Fischbach W, Goebeler-Kolve M, Dragosics B, Greiner A, Stolte M . Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series. Gut. 2003; 53(1):34-7. PMC: 1773912. DOI: 10.1136/gut.53.1.34. View

Tomasini R, Seux M, Nowak J, Bontemps C, Carrier A, Dagorn J . TP53INP1 is a novel p73 target gene that induces cell cycle arrest and cell death by modulating p73 transcriptional activity. Oncogene. 2005; 24(55):8093-104. DOI: 10.1038/sj.onc.1208951. View

Kusters J, Van Vliet A, Kuipers E . Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev. 2006; 19(3):449-90. PMC: 1539101. DOI: 10.1128/CMR.00054-05. View

Xiao C, Calado D, Galler G, Thai T, Patterson H, Wang J . MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell. 2007; 131(1):146-59. DOI: 10.1016/j.cell.2007.07.021. View

Lawrie C . MicroRNA expression in lymphoid malignancies: new hope for diagnosis and therapy?. J Cell Mol Med. 2008; 12(5A):1432-44. PMC: 3918059. DOI: 10.1111/j.1582-4934.2008.00399.x. View

L Bartels C, Tsongalis G . MicroRNAs: novel biomarkers for human cancer. Clin Chem. 2009; 55(4):623-31. DOI: 10.1373/clinchem.2008.112805. View

Ferreri A, Ernberg I, Copie-Bergman C . Infectious agents and lymphoma development: molecular and clinical aspects. J Intern Med. 2009; 265(4):421-38. DOI: 10.1111/j.1365-2796.2009.02083.x. View

10.

OConnell R, Chaudhuri A, Rao D, Baltimore D . Inositol phosphatase SHIP1 is a primary target of miR-155. Proc Natl Acad Sci U S A. 2009; 106(17):7113-8. PMC: 2678424. DOI: 10.1073/pnas.0902636106. View

11.

Xiao B, Liu Z, Li B, Tang B, Li W, Guo G . Induction of microRNA-155 during Helicobacter pylori infection and its negative regulatory role in the inflammatory response. J Infect Dis. 2009; 200(6):916-25. DOI: 10.1086/605443. View

12.

Navarro A, Diaz T, Martinez A, Gaya A, Pons A, Gel B . Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma. Blood. 2009; 114(14):2945-51. DOI: 10.1182/blood-2009-02-204842. View

13.

Wu Q, Jin H, Yang Z, Luo G, Lu Y, Li K . MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2. Biochem Biophys Res Commun. 2010; 392(3):340-5. DOI: 10.1016/j.bbrc.2009.12.182. View

14.

Zhang X, Zhu W, Zhang J, Huo S, Zhou L, Gu Z . MicroRNA-650 targets ING4 to promote gastric cancer tumorigenicity. Biochem Biophys Res Commun. 2010; 395(2):275-80. DOI: 10.1016/j.bbrc.2010.04.005. View

15.

OConnell R, Kahn D, Gibson W, Round J, Scholz R, Chaudhuri A . MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity. 2010; 33(4):607-19. PMC: 2966521. DOI: 10.1016/j.immuni.2010.09.009. View

16.

Tsuchiya S, Fujiwara T, Sato F, Shimada Y, Tanaka E, Sakai Y . MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1). J Biol Chem. 2010; 286(1):420-8. PMC: 3013001. DOI: 10.1074/jbc.M110.170852. View

17.

Chen C, Zhang Y, Zhang L, Weakley S, Yao Q . MicroRNA-196: critical roles and clinical applications in development and cancer. J Cell Mol Med. 2010; 15(1):14-23. PMC: 3276076. DOI: 10.1111/j.1582-4934.2010.01219.x. View

18.

Du M . MALT lymphoma: many roads lead to nuclear factor-κb activation. Histopathology. 2011; 58(1):26-38. DOI: 10.1111/j.1365-2559.2010.03699.x. View

19.

Craig V, Cogliatti S, Rehrauer H, Wundisch T, Muller A . Epigenetic silencing of microRNA-203 dysregulates ABL1 expression and drives Helicobacter-associated gastric lymphomagenesis. Cancer Res. 2011; 71(10):3616-24. DOI: 10.1158/0008-5472.CAN-10-3907. View

20.

Yao Y, Suo A, Li Z, Liu L, Tian T, Ni L . MicroRNA profiling of human gastric cancer. Mol Med Rep. 2011; 2(6):963-70. DOI: 10.3892/mmr_00000199. View